Parkside Financial Bank & Trust’s Amicus Therapeutics FOLD Stock Holding History

Parkside Financial Bank & Trust’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-270	Closed	-$3.9K	–	2741
2026 Q1	$3.9K	Hold	270	–	–	﹤0.01%	1903
2025 Q4	$3.85K	Hold	270	–	–	﹤0.01%	1888
2025 Q3	$2.13K	Buy	270 +180	+200%	+$1.28K	﹤0.01%	1998
2025 Q2	$534	Sell	90 -20	-18%	-$129	﹤0.01%	2511
2025 Q1	$897	Buy	+110	New	+$1.02K	﹤0.01%	2145

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Parkside Financial Bank & Trust's FOLD Position: Q2 2026 in Review

Parkside Financial Bank & Trust sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 270 shares — an estimated $3.9K sold.

Parkside Financial Bank & Trust first reported a position in FOLD in Q1 2025 and held it in 5 quarters. The position peaked at $3.9K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Parkside Financial Bank & Trust reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Parkside Financial Bank & Trust sold 270 Amicus Therapeutics shares in Q2 2026, an estimated $3.9K.
Parkside Financial Bank & Trust first reported a position in Amicus Therapeutics in Q1 2025 and held it in 5 quarters.
Parkside Financial Bank & Trust's Amicus Therapeutics position peaked at $3.9K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.